ETHEMA HEALTH CORPORATION - GRST STOCK NEWS

Ethema Health 's subsidiary ARIA received a full license for inpatient detoxification and Residential Level 1 facility in Boca Raton on October 21, 2024. The ARIA Boca facility features 11 detox beds and 12 residential beds, increasing total Florida bed count to 85. While Q3 revenue from ARIA Boca was delayed pending insurer contract updates, ARIA's Q3 2024 revenues grew 18% from Q2 2024 and 30% from Q3 2023. The company expects ARIA Boca revenue generation in Q4 2024 and plans to complete the Edgewater Recovery center acquisition in Kentucky during the same quarter. Management aims for an uplisting in H1 2025.

Ethema Health (OTCPINK: GRST) has signed a binding Asset Purchase Agreement to acquire the business operations and operational assets of Edgewater Recovery Center, (ERC) in Kentucky. The transaction excludes real property and requires various consents. ERC has been managed by Ethema since July 15, 2024, and will continue operations until ARIA Kentucky, a new subsidiary, is fully licensed and accredited.

The current ERC patient census is approximately 195 patients, with expectations of significant growth. Ethema plans to add 16 beds in October at the Paducah location. ARIA Kentucky will primarily serve Medicaid-insured clients, with potential for expansion due to ongoing investigations into other Medicaid providers in the state.

The real property associated with ERC operations will be acquired separately by a fund controlled by Ethema's CEO, Shawn Leon, and leased to ARIA Kentucky at market rates.

Ethema Health (OTCPINK: GRST) has received a license for its new 16-bed inpatient detoxification and 16-bed residential level 1 facility in Boca Raton, Florida. This increases the company's total bed count in Florida to 94. Ethema is also negotiating to purchase facilities in Kentucky, potentially adding 60 more beds.

The company is considering setting up a separate Real Estate Fund and plans to announce a new Preferred Stock offering. CEO Shawn Leon will present at the 1640 Society gathering in Southampton, New York. Ethema has reset its growth target to 3,000 beds by the end of 2027. The company is also discussing potential up-listing, a convertible preferred stock offering, and future cash dividends.

Ethema Health (OTCPINK: GRST) is set to present at the Emerging Growth Healthcare Conference on July 18, 2024 at 10:15 AM Eastern time. CEO Shawn Leon will discuss the company and the effects of the recently announced LOI for the purchase and management of Edgewater Recovery Center .

The live, interactive online event allows shareholders and investors to engage with the CEO in real-time. Attendees can submit questions in advance or during the event. Registration is required to attend and receive updates.

Additionally, Shawn Leon was interviewed by SaveChangeWorld.com on July 14, 2024, primarily discussing Ethema's acquisition of Edgewater Recovery Center. The recorded interview, available on their website, includes projections and Ethema's ongoing financing strategy.

Ethema Health (GRST) has signed a Letter of Intent (LOI) to acquire all assets of Edgewater Recovery Center (ERC), including three real estate holding companies. The agreement also includes a management deal effective July 15, 2024, until the acquisition closes on January 31, 2025. ERC operates in Morehead and Paducah, Kentucky, with around 440 licensed beds and an additional 66 beds coming online in 2024. The acquisition is expected to help Ethema reach its goal of 500 beds by the end of 2025. The deal will also allow Ethema to pursue a sale-leaseback transaction for working capital without new equity. Ethema’s CEO, Shawn Leon, highlighted the strategic benefits, including expanding Medicaid-insured care and up-listing plans.

Ethema Health Corporation (GRST) will be giving a live update at the next Emerging Growth Conference on February 8, 2024. The CEO will provide an update on the previous presentation and answer questions from shareholders and the investment community. The company also presented at the Deal Flow Microcap Conference and received unanimous support for its growth plans.

Ethema Health Corporation, ticker symbol GRST, will be participating in The Microcap Conference on January 30, 31, and February 1, 2024, with CEO Shawn Leon presenting on January 31 & February 1. The event will take place at Caesars Atlantic City Hotel & Casino in Atlantic City, NJ. Interested parties can register to attend and have one-on-one meetings with the management team.

Ethema Health Corporation (GRST) has been invited to present at the next Emerging Growth Conference, giving shareholders and the investment community the opportunity to interact with the Company’s CEO Shawn Leon. Mr. Leon will present Ethema’s outlook for 2024 and answer questions during the live, interactive online event on January 10 and 11, 2024.

Ethema Health Corporation (GRST) reported a significant improvement in financial performance in the third quarter of 2023, with a net income of $1,529,599 for the nine months ended September 30, 2023, compared to a net loss of $167,162 for the same period in 2022. The company attributes this increase to profits from the purchase and sale of its real estate leased by its ARIA subsidiary. ARIA subsidiary's EBITDA for the nine months ended September 30, 2023, was $883,603, and the Company's wholly owned subsidiary, PB Billing LLC, reported an EBITDA of $50,860. The CEO, Mr. Shawn Leon, expressed satisfaction with the significant income numbers, balance sheet improvement, and debt reduction. The company is also focused on raising new equity investment through its Reg A+ offering and new strategic partners, priced above the current market prices.